Molecular characterization of the putative T-cell receptor cavity of the superantigen staphylococcal enterotoxin B.
A number of investigators have utilized a variety of methods to identify the structural basis for the interaction of superantigens with the T-cell receptor beta-chain. The previous studies strongly suggest that a region of the toxin near residues N23, Y61, Y91 and D209 is important for this binding activity. Examination of crystal structure data shows that these residues line the rim of one side of a shallow cavity in the toxin. In an attempt further to define the face of the staphylococcal enterotoxin B (SEB) molecule involved in the interaction with the beta-chain, we have employed a polymerase chain reaction (PCR)-based, site-specific mutagenesis method to generate amino acid substitutions of residues on the opposite side of this putative T-cell receptor interaction cavity. Our results show that Y175 and N179 appear to be involved in the function of this superantigen, since each of several substitutions at this position exhibits a significantly reduced ability to induce T-cell proliferation. At the same time, mutation of the proximal Y186 does not alter the superantigen activity of SEB. Binding analysis of these mutants shows that class II binding activity is not significantly altered. Analysis of the responding T cells shows that the mutant toxins maintain T-cell receptor V beta selectivity. However, responses of T cells bearing the V beta 8.1 allele appear to be particularly diminished. When viewed in the context of other results reported in the literature, our results suggest that the T-cell receptor interaction site involves SEB residues which ring both the Y175/N179-side and the N23-side of a cavity on one side of the toxin molecule.
Garcia
C
C
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Briggs
C
C
Zhang
L
L
Guan
L
L
Gabriel
J L
JL
Rogers
T J
TJ
D000483:Alleles; D000818:Animals; D002455:Cell Division / Q000276:immunology; D004768:Enterotoxins / Q000737:chemistry* / Q000276:immunology / Q000302:isolation & purification; D015798:HLA-DR1 Antigen / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D008934:Mitogens / Q000276:immunology; D016297:Mutagenesis, Site-Directed; D016133:Polymerase Chain Reaction; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology*; D013211:Staphylococcus aureus / Q000276:immunology*; D013329:Structure-Activity Relationship; D018089:Superantigens / Q000737:chemistry* / Q000276:immunology / Q000302:isolation & purification
D004768:Enterotoxins; D015798:HLA-DR1 Antigen; D008934:Mitogens; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; C031818:enterotoxin B, staphylococcal